![]() | W PruzanskiDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, School of Medicine, Philadelphia. | From the Department of Medicine and the Immunoproteins ... |
KOL Resume for W Pruzanski
Year | |
---|---|
1991 | Department of Pathology and Laboratory Medicine, University of Pennsylvania, School of Medicine, Philadelphia. |
1969 | From the Department of Medicine and the Immunoproteins Research Laboratory, University of Toronto Rheumatic Disease Unit, The Wellesley Hospital, Toronto, Ontario, Canada |
1966 | “ASAF HAROFE” GOVERNMENT HOSPITAL MEDICAL “B” DEPARTMENT, ZERIFIN, ISRAEL |
W Pruzanski: Influence Statistics
Concept | World rank |
---|---|
mra bence | #1 |
serum waldenströms macroglobulinemia | #1 |
pga 77 | #1 |
igg commonest class | #1 |
immunoquantitation igm | #1 |
hamartoma heavy | #1 |
class myeloma | #1 |
mra pga | #1 |
pga mra | #1 |
limited clinical expression | #1 |
mra bence jones | #1 |
splenomegaly hyperviscosity syndrome | #1 |
falsepositive vdrl tests | #1 |
hyperviscosity syndrome splenomegaly | #1 |
pga proteinuria | #1 |
readings immunoquantitation | #1 |
amyloidosis pga | #1 |
primary generalized amyloidosis | #1 |
amyloidosis mra | #1 |
7 dysgammaglobulinaemic | #1 |
sexes igd myeloma | #1 |
class type component | #1 |
splenomegaly splenomegaly syndrome | #1 |
bence jones pga | #1 |
commonest class myeloma | #1 |
rheumatoidarthritislike syndrome | #1 |
igm igg complexes | #1 |
usual chief complaints | #1 |
igd myeloma incidence | #1 |
lct igm class | #2 |
bence jones igd | #2 |
reaction hamartoma | #2 |
multiple myeloma igg | #2 |
77 mra | #2 |
components pga | #3 |
hyperviscosity syndrome association | #3 |
smooth muscle involvement | #4 |
influence chemotherapeutic agents | #5 |
icba human | #5 |
pga limited | #5 |
serum concentration igm | #6 |
idiotype 463 | #6 |
enhanced icba | #6 |
dysgammaglobulinemia graft | #6 |
amyloid lymphadenopathy | #7 |
bence jones proteinemia | #7 |
iga igg patients | #7 |
myeloma lambda | #7 |
greater 250 24 | #7 |
influence chemotherapeutic | #8 |
Open the FULL List in Excel | |
Prominent publications by W Pruzanski
Three patients, one with plasma cell leukemia and clinically asymptomatic hypernephroma and meningioma, and two others with multiple myeloma, had M-components of IgD/lambda type. In the first case, IgD globulin was found in the serum, ascitic and pleural fluids. Including our patients, 50 cases of IgD myeloma have been reported in the literature. A review of this group showed some significant differences from the other classes of multiple myeloma. IgD myeloma seems to involve a larger ...
Known for Igd Myeloma | Plasma Cell | Bence Jones | Protein Electrophoresis | Pleural Effusion |
Among 1242 patients referred for immunologic investigation 1255 M components were detected in the serum. Of these patients 50.9% had multiple myeloma, 18.1% had nonmyelomatous malignant diseases such as macroglobulinemia, lymphoma, leukemia or cancer, 4.3% had connective tissue diseases, 2.5% had primary generalized amyloidosis (PGA) and the rest had various "benign" conditions. Whereas IgG was the commonest M component in multiple myeloma, connective tissue diseases and the other benign ...
Known for Multiple Myeloma | Bence Jones | Benign Conditions | Light Chains | Leukemia Lymphoma |
The hyperviscosity syndrome is most commonly seen in association with monoclonal gammopathies and has only rarely been described in association with polyclonal hypergammaglobulinemia. We have recently seen a patient with known acquired immunodeficiency syndrome who presented with the hyperviscosity syndrome in the setting of polyclonal hypergammaglobulinemia. To our knowledge, this is the first reported case of a patient with the acquired immunodeficiency syndrome and the hyperviscosity ...
Known for Hyperviscosity Syndrome | Acquired Immunodeficiency | Blood Viscosity | Humans Hypergammaglobulinemia |
Key People For Hyperviscosity Syndrome
W Pruzanski:Expert Impact
Concepts for whichW Pruzanskihas direct influence:Hyperviscosity syndrome, Chemotherapeutic agents, West nile, Multiple myeloma, Bactericidal activity, Clinical manifestations, Papular mucinosis, Igd myeloma.
W Pruzanski:KOL impact
Concepts related to the work of other authors for whichfor which W Pruzanski has influence:Multiple myeloma, Rheumatoid arthritis, Arachidonic acid, Secretory phospholipase, Myotonic dystrophy, Cold agglutinins, Hyperviscosity syndrome.
Tools
Is this your profile? Claim your profile Copy URL Embed Link to your profile |